What are the symptoms and treatment options for Adult Onset Still's Disease (AOSD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adult-Onset Still's Disease: Clinical Manifestations

Adult-Onset Still's Disease (AOSD) presents with a classic triad of high-spiking fevers (>39°C), evanescent salmon-pink rash, and arthritis/arthralgia, occurring in over 95% of patients for fever and 64-100% for joint involvement. 1

Core Clinical Features

Fever Pattern

  • High-spiking fevers exceeding 39°C that are transient, lasting typically under 4 hours 1
  • Quotidian or double quotidian pattern with highest temperatures in late afternoon or early evening 1
  • Fever heralds the onset of other manifestations including serositis, sore throat, myalgias, and arthralgias 1
  • Overall incidence across major studies: 95.7% 1

Characteristic Rash

  • Evanescent, salmon-pink, maculopapular eruption predominantly on proximal limbs and trunk 1
  • Rare involvement of face and distal limbs 1
  • Often accompanied by fever and can be mildly pruritic, frequently confused with drug allergy 1
  • Koebner phenomenon has been described 1
  • Incidence ranges from 51% to 87%, with average of 72.7% 1

Articular Manifestations

  • Arthralgia and arthritis occur in 64-100% of patients 1
  • Most frequently affected joints: knees (69-82%), wrists (67-73%), and ankles (38-55%) 1
  • Carpal and pericapitate abnormalities are typically higher than in rheumatoid arthritis, offering diagnostic differentiation 1
  • Wrist changes typically present 6 months after disease onset, with progressive joint space narrowing in pericapitate or carpometacarpal distribution 1
  • Ankylosis develops after 1.5-3 years 1
  • Pattern is typically symmetric polyarthritis with joint pain associated with fever spikes 1

Additional Systemic Manifestations

Pharyngeal and Muscular

  • Sore throat: 35-92% of patients across major series 1
  • Myalgia: 56-84% incidence, generalized and appearing with fever exacerbations 1
  • Inflammatory myopathy is rare, though muscle enzyme elevation has been reported 1

Lymphoreticular System

  • Lymphadenopathy: 32-74% of patients 1
  • Splenomegaly: 14-65% of patients 1

Serositis

  • Pleuritis: 12-53% of patients 1
  • Pericarditis: 10-37% of patients 1

Hepatic Involvement

  • Hepatomegaly and liver biochemistry abnormalities present in approximately 50-75% of patients 1
  • AOSD can present as pseudo-angiocholitis 1
  • Jaundice and acute hepatitis leading to hepatic failure remain exceedingly rare 1

Laboratory Abnormalities

Inflammatory Markers

  • ESR elevated in virtually all patients in major series 1
  • CRP typically raised 1

Hematologic Abnormalities

  • Leucocytosis with striking neutrophilia: 50% of patients have counts >15×10⁹ cells/L, 37% have WBC >20×10⁹ 1
  • Anaemia of chronic disease seen with active disease, often normalizes with remission 1
  • Reactive thrombocytosis is common 1
  • Pancytopenia should alert to haemophagocytic syndrome, which requires prompt immunosuppressive treatment 1

Ferritin

  • Very high ferritin levels ranging from 4,000-30,000 ng/mL are common, with extreme levels up to 250,000 ng/mL reported 1
  • Serum ferritin correlates with disease activity and often normalizes with remission 1

Disease Patterns

AOSD follows three distinct clinical patterns, each affecting approximately one-third of patients 2:

  • Self-limited/monocyclic: Systemic symptoms with remission within 1 year (median 9 months) 2
  • Intermittent/polycyclic: Recurrent flares with complete remission between episodes 2
  • Chronic articular: Dominated by joint manifestations that can lead to severe joint destruction 2

Critical Complications

Macrophage Activation Syndrome (MAS)

  • Most life-threatening complication with high mortality rate 3
  • Reported in up to 23% of AOSD patients 3
  • Requires high-dose glucocorticoids and high-dose anakinra (>4 mg/kg/day in children or 100 mg twice daily in adults) 2
  • Cyclosporine A and/or IFN-γ inhibitors may be considered 2

Coagulation Abnormalities

  • Rare but include prolongations of PTT or PT 1
  • Disseminated intravascular coagulation has been described and can be fatal 1
  • Risk factors include severe disease activity, liver abnormalities, and particular drugs (salicylates, NSAIDs, some DMARDs) 4

Diagnostic Considerations

  • AOSD is a diagnosis of exclusion requiring elimination of infectious, neoplastic, and other autoimmune diseases 5
  • Yamaguchi criteria are most widely used, though Fautrel criteria offer benefit of adding ferritin and glycosylated ferritin values 6
  • AOSD is responsible for a significant proportion of fever of unknown origin cases 5
  • Differential diagnosis must exclude malignant hematological disorders, especially when lymphadenopathy, splenomegaly, fever, and leukocytosis dominate 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Adult-Onset Still's Disease (AOSD)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Adult-onset Still's disease.

Bailliere's clinical rheumatology, 1991

Guideline

Adult-Onset Still's Disease Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Adult-Onset Still's Disease-A Complex Disease, a Challenging Treatment.

International journal of molecular sciences, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.